Dominion Aesthetic Technologies Inc reported on Tuesday the receipt of US FDA clearance for its medical, non-contact body contouring product, eon FR.
The company added that the eon FR is capable of reducing fat over a larger surface area than its competitors, which is highly desired by both physicians and patients. The body shaping technology delivers non-contact, laser energy to reduce fat in the abdomen using a patent-pending powered articulated arm.
According to the company, the eon FR causes the death of fat cells through apoptosis process that takes from six to 12 weeks and after the eon FR body contouring treatment, the body naturally eliminates fat cells through its lymphatic system. The treatment takes about 15 minutes to perform with no downtime.
Headquartered in San Antonio, TX, the laser-based medical device company offers the best innovative tools to serve the physicians' practices and the patients' needs.
OSR Holdings to acquire Korean non-invasive glucose monitor developer Woori IO
Autonomix Medical secures new US patent to expand precision nerve-targeted therapies
MedHub-AI's AutocathFFR receives national reimbursement approval in Japan
Microbot Medical secures first Japanese patent for Liberty robotic system following FDA clearance
Polarean Imaging signs new supply agreementwith UVA Health for clinical Xenon MRI
Femasys partners with Kebomed to expand FemBloc permanent birth control in France and Benelux
Implantica receives positive FDA feedback on final RefluxStop PMA submission
Tempus secures FDA clearance for RNA-based xR IVD diagnostic device
Shoulder Innovations expands I-Series portfolio with launch of InSet 70 Humeral Stem
GSK commits USD30bn to US R&D and manufacturing expansion
ArtPlayer Promotes Elderly Wellbeing with Digital Signage and Streaming Art in Finnish Care Homes
Implantica produces 10,000 RefluxStop units ahead of planned US launch
Elute partners Spartan Medical
Saol Therapeutics receives US FDA Complete Response Letter for SL1009 (DCA) in PDCD